★ Private Action
Eli Lilly pledges $27B in U.S. manufacturing under Trump
Filed November 2025$27,000,000,000
★ The Brief
What happened
The pledge was announced in a White House fact sheet tied to Most-Favored-Nation drug pricing, the administration's framework for capping U.S. drug prices to international levels.
Who enabled it
Under the Trump administration, Eli Lilly announced at least $27 billion in new U.S. manufacturing investments, described in the White House fact sheet as occurring under President Trump's leadership. The investments are intended to expand domestic pharmaceutical manufacturing capacity.
Further reading
- ★ Government ActionAugust 2025Trump doubles India tariffs to 50% on day of Apple investment event
- ★ Private ActionAugust 2025Apple adds $100B to U.S. manufacturing pledge, total $600B
- ★ Private ActionAugust 2025Tim Cook gifts Trump gold souvenir during Apple tariff lobbying
- ★ Government ActionAugust 2025Trump exempts Apple and other tech investors from 100% chip tariffs
- ★ Private ActionJuly 2025Rolex gifts Trump a desk clock during Swiss tariff lobbying
- ★ Government ActionJuly 2025Trump cuts Swiss tariffs 39% to 15% after Rolex lobbying